Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations - PubMed (original) (raw)
Comparative Study
. 2008 Dec 1;112(12):4507-11.
doi: 10.1182/blood-2008-04-152967. Epub 2008 Aug 8.
Affiliations
- PMID: 18689547
- DOI: 10.1182/blood-2008-04-152967
Free article
Comparative Study
Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations
Oliver Tunstall-Pedoe et al. Blood. 2008.
Free article
Abstract
Down syndrome (DS) children have a high frequency of acute megakaryoblastic leukemia (AMKL) in early childhood. At least 2 in utero genetic events are required, although not sufficient, for DS-AMKL: trisomy 21 (T21) and N-terminal-truncating GATA1 mutations. To investigate the role of T21 in DS-AMKL, we compared second trimester hemopoiesis in DS without GATA1 mutations to gestation-matched normal controls. In all DS fetal livers (FLs), but not marrows, megakaryocyte-erythroid progenitor frequency was increased (55.9% +/- 4% vs 17.1% +/- 3%, CD34(+)CD38(+) cells; P < .001) with common myeloid progenitors (19.6% +/- 2% vs 44.0% +/- 7%) and granulocyte-monocyte (GM) progenitors (15.8% +/- 4% vs 34.5% +/- 9%) commensurately reduced. Clonogenicity of DS-FL versus normal FL CD34(+) cells was markedly increased (78% +/- 7% vs 15% +/- 3%) affecting megakaryocyte-erythroid ( approximately 7-fold higher) and GM and colony-forming unit-granulocyte, erythrocyte macrophage, megakaryocyte (CFU-GEMM) progenitors. Replating efficiency of CFU-GEMM was also markedly increased. These data indicate that T21 itself profoundly disturbs FL hemopoiesis and they provide a testable hypothesis to explain the increased susceptibility to GATA1 mutations in DS-AMKL and DS-associated transient myeloproliferative disorder.
Similar articles
- Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Greene ME, Mundschau G, Wechsler J, McDevitt M, Gamis A, Karp J, Gurbuxani S, Arceci R, Crispino JD. Greene ME, et al. Blood Cells Mol Dis. 2003 Nov-Dec;31(3):351-6. doi: 10.1016/j.bcmd.2003.08.001. Blood Cells Mol Dis. 2003. PMID: 14636651 - Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.
Vyas P, Roberts I. Vyas P, et al. Early Hum Dev. 2006 Dec;82(12):767-73. doi: 10.1016/j.earlhumdev.2006.09.016. Epub 2006 Oct 24. Early Hum Dev. 2006. PMID: 17064858 Review. - Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
Rainis L, Bercovich D, Strehl S, Teigler-Schlegel A, Stark B, Trka J, Amariglio N, Biondi A, Muler I, Rechavi G, Kempski H, Haas OA, Izraeli S. Rainis L, et al. Blood. 2003 Aug 1;102(3):981-6. doi: 10.1182/blood-2002-11-3599. Epub 2003 Mar 20. Blood. 2003. PMID: 12649131 - Natural history of GATA1 mutations in Down syndrome.
Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O'Marcaigh A, Wynn R, Stevens R, Addison M, King D, Stewart B, Gibson B, Roberts I, Vyas P. Ahmed M, et al. Blood. 2004 Apr 1;103(7):2480-9. doi: 10.1182/blood-2003-10-3383. Epub 2003 Dec 4. Blood. 2004. PMID: 14656875 - Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.
Roy A, Roberts I, Norton A, Vyas P. Roy A, et al. Br J Haematol. 2009 Oct;147(1):3-12. doi: 10.1111/j.1365-2141.2009.07789.x. Epub 2009 Jul 6. Br J Haematol. 2009. PMID: 19594743 Review.
Cited by
- GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development.
Takasaki K, Chou ST. Takasaki K, et al. Adv Exp Med Biol. 2024;1459:261-287. doi: 10.1007/978-3-031-62731-6_12. Adv Exp Med Biol. 2024. PMID: 39017848 Review. - Chromosome silencing in vitro reveals trisomy 21 causes cell-autonomous deficits in angiogenesis and early dysregulation in Notch signaling.
Moon JE, Lawrence JB. Moon JE, et al. Cell Rep. 2022 Aug 9;40(6):111174. doi: 10.1016/j.celrep.2022.111174. Cell Rep. 2022. PMID: 35947952 Free PMC article. - First-Trimester Fetal Hepatic Artery Examination for Adverse Outcome Prediction.
Czuba B, Tousty P, Cnota W, Borowski D, Jagielska A, Dubiel M, Fuchs A, Fraszczyk-Tousty M, Dzidek S, Kajdy A, Świercz G, Kwiatkowski S. Czuba B, et al. J Clin Med. 2022 Apr 8;11(8):2095. doi: 10.3390/jcm11082095. J Clin Med. 2022. PMID: 35456191 Free PMC article. - Fetal vs adult megakaryopoiesis.
Davenport P, Liu ZJ, Sola-Visner M. Davenport P, et al. Blood. 2022 Jun 2;139(22):3233-3244. doi: 10.1182/blood.2020009301. Blood. 2022. PMID: 35108353 Free PMC article. - Effects of aneuploidy on cell behaviour and function.
Li R, Zhu J. Li R, et al. Nat Rev Mol Cell Biol. 2022 Apr;23(4):250-265. doi: 10.1038/s41580-021-00436-9. Epub 2022 Jan 5. Nat Rev Mol Cell Biol. 2022. PMID: 34987171 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials